Merit Cudkowicz, MD
Enriched profileChief, Neurology Service, Massachusetts General Hospital; Director, Sean M. Healey & AMG Center for ALS; Julieanne Dorn Professor of Neurology, Harvard Medical School; Executive Director, Mass General Brigham Neuroscience Institute · Massachusetts General Hospital
Merit Cudkowicz is Chief, Neurology Service, Massachusetts General Hospital; Director, Sean M. Healey & AMG Center for ALS; Julieanne Dorn Professor of Neurology, Harvard Medical School; Executive Director, Mass General Brigham Neuroscience Institute at Massachusetts General Hospital. OpenAlex indexes 429 publications with 29,229 citations (h-index 93); ClinicalTrials.gov lists 24 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 16 Oct 2026
Merit Cudkowicz, MD, is Chief, Neurology Service, Massachusetts General Hospital. The public record shows 429 publications with 29,229 citations (h-index 93), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Genetic Neurodegenerative Diseases. It also documents an investigator role on 24 registered clinical trials, industry payments reported by 14 companies, 11 NIH-funded awards (1996–2026).
- Most recent indexed publication: 2026 · Nature
- Top research focus: Amyotrophic Lateral Sclerosis Research
- 24 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 256.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Witness testimony
U.S. House Energy & Commerce Committee, Health Subcommittee hearing 'The Path Forward: Advancing Treatments and Cures for Neurodegenerative Diseases' (July 29, 2021) …
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →democrats-energycommerce.house.gov ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 24 registered studies on ClinicalTrials.gov. The most recent:
- HEALEY ALS Platform Trial - Regimen I NUZ-001
Sponsor: Merit E. Cudkowicz, MD
- HEALEY ALS Platform Trial - Regimen G DNL343
Sponsor: Merit E. Cudkowicz, MD
- HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262
Sponsor: Merit E. Cudkowicz, MD
Industry payments
Updated 16 Oct 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- BioMarin Pharmaceutical Inc.Program year20251 payment
- Shionogi IncProgram year20251 payment
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.2%Other nervous system drugs48.8%Radicava Ors100%Part D≥22 patientsBenzothiazole29.4%Riluzole80%Teglutik21%Part D<11 patients+ 1 more class in this area
Cardiovascular
5.8%Statin5.8%Lovastatin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
11 NIH research awards on record, funded 1996–2026 per NIH RePORTER. The latest:
- Gene Therapy Consortium (GTC) for Gene-Based Clinical Trials Conducted within NeuroNEXT
Massachusetts General Hospital
FY2026$2,981,723OT2NS138339 - Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)
Massachusetts General Hospital
FY2026$2,770,869U01NS077179 - Clinical Coordinating Center for the Network of Excellence in Neuroscience Clinical Trials (NEXT - CCC)
Massachusetts General Hospital
FY2025$2,770,869U01NS077179
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- The Amyotrophic Lateral Sclerosis House Call Program: A Single-Center Experience in the United States.
Neurology research international
Article2026 - An Expanded Access Protocol of RNS60 in Amyotrophic Lateral Sclerosis.
Muscle & nerve
Clinical Trial2025
Most-cited works
by citation count (OpenAlex)- 01
- 02Trial of Antisense Oligonucleotide Tofersen for <i>SOD1</i> ALSArticle872 citations2022
- 03
- 04Genome-wide Analyses Identify KIF5A as a Novel ALS GeneArticle723 citations2018
- 05
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/merit-cudkowicz-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/merit-cudkowicz-72124057
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - X / Twitter
x.com/MeritCudkowicz
- LinkedIn
linkedin.com/in/merit-cudkowicz-07176553
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Instagram
instagram.com/massgeneral/p/C7PdCUTAFfO
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/mdaorg/p/Cpc2a8rtjFA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - X / Twitter
x.com/MGHNeurology/status/1908946556767645924
- X / Twitter
x.com/MassGenBrigham/status/1960326361622438379
- X / Twitter
x.com/NEALSConsortium/status/1400801969682407429
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Harvard Medical School (Health Sciences and Technology program)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - MSc in Clinical Epidemiology
Harvard T.H. Chan School of Public Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - BS in Chemical Engineering
Massachusetts Institute of Technology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Board Certified
Neurology, American Board of Psychiatry & Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →massgeneral.org ↗
Editorial & leadership roles
journal and society appointments- Associate Editor
Annals of Clinical and Translational Neurology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onlinelibrary.wiley.com ↗ - Principal Investigator
HEALEY ALS Platform Trial (first platform trial initiative in ALS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →worldmedicalinnovation.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myana.org ↗
- Co-founder and past Co-Chair
Northeast ALS Consortium (NEALS)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Principal Investigator
Clinical Coordination Center, NINDS Neurology Network of Excellence in Clinical Trials (NeuroNEXT)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Faculty affiliate
Harvard Brain Science Initiative
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →brain.harvard.edu ↗
Media & interviews
press, podcasts and appearances- Guest
Tim Green NLU Podcast, Episode #2, 'Dr. Merit Cudkowicz: ALS, New Treatments, AI, Neurology, Harvard'
2024verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - Guest
Berry Consultants podcast, 'HEALEY ALS Platform Trial with Dr. Merit Cudkowicz and Dr. Melanie Quintana'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →berryconsultants.com ↗ - Featured guest
Mass General 'Charged' podcast/video series episode profile
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneral.org ↗ - Interviewed
CGTLive, 'Merit Cudkowicz, MD, on Evaluating Mesenchymal Cell Therapy for ALS'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cgtlive.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neurologylive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida